Jodofenpropit
Nazivi | |
---|---|
IUPAC naziv 3-(1H-imidazol-5-il)propil N'-[2-(4-jodofenil)etil]imidotiokarbamat | |
Drugi nazivi 1-[3-(3H-imidazol-4-il)propiltio]-N'-[2-(4-jodofenil)etil]formamidin | |
Identifikacija | |
| |
3D model (Jmol) |
|
MeSH | Iodophenpropit |
| |
SMILES
| |
Svojstva | |
C15H19IN4S | |
Molarna masa | 414,30763 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Y verifikuj (šta je YН ?) | |
Reference infokutije | |
Jodofenpropit je histaminski antagonist koji se selektivno vezuje za histaminski H3 receptor. Njegov 125I radioobeležen oblik se koristi za mapiranje distribucije H3 receptora u telu.[3][4]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Jansen, FP; Wu, TS; Voss, HP; Steinbusch, HW; Vollinga, RC; Rademaker, B; Bast, A; Timmerman, H (1994). „Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, 125I-iodophenpropit, to rat brain”. British Journal of Pharmacology. 113 (2): 355—62. PMC 1510107 . PMID 7834183.
- ^ Jansen, FP; Mochizuki, T; Maeyama, K; Leurs, R; Timmerman, H (2000). „Characterization of histamine H3 receptors in mouse brain using the H3 antagonist 125Iiodophenpropit”. Naunyn-Schmiedeberg's archives of pharmacology. 362 (1): 60—7. PMID 10935534. doi:10.1007/s002100000227.
Spoljašnje veze
- p
- r
- u
Histaminergici
VMAT |
---|
HDC | |
---|---|
HNMT | |
DAO | Inhibitori: Aminoguanidin |
Endogeni | Histamin; Prekursori: L-Histidin; Kofaktori: Vitamin B6 |
---|